CBIH (Cannabis Bioscience International Holdings) EV-to-OCF: -10.09 (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Cannabis Bioscience International Holdings EV-to-OCF?

Cannabis Bioscience International Holdings CBIH EV-to-OCF is -10.09 as of Sep. 20, 2026. The stock has 4 warning signs investors should review. Among 1,007 Drug Manufacturers companies, Cannabis Bioscience International Holdings ranks better than 82.03% on this metric.

EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Cannabis Bioscience International Holdings's Enterprise Value is $2.73 Mil. Cannabis Bioscience International Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Feb. 2026 was $-0.27 Mil. Therefore, Cannabis Bioscience International Holdings's EV-to-OCF for today is -10.09.

The historical rank and industry rank for Cannabis Bioscience International Holdings's EV-to-OCF or its related term are showing as below:

CBIH' s EV-to-OCF Range Over the Past 10 Years
Min: -10.08   Med: 0   Max: -5.79
Current: -10.08

During the past 13 years, the highest EV-to-OCF of Cannabis Bioscience International Holdings was -5.79. The lowest was -10.08. And the median was .

CBIH's EV-to-OCF is ranked better than
82.03% of 1007 companies
in the Drug Manufacturers industry
Industry Median: 10.12 vs CBIH: -10.08

EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-09-20), Cannabis Bioscience International Holdings's stock price is $0.0002. Cannabis Bioscience International Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2026 was $0.000. Therefore, Cannabis Bioscience International Holdings's PE Ratio (TTM) for today is N/A.


Cannabis Bioscience International Holdings  (OTCPK:CBIH) EV-to-OCF Explanation

EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Cannabis Bioscience International Holdings's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0002/0.000
=N/A

Cannabis Bioscience International Holdings's share price for today is $0.0002.
Cannabis Bioscience International Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Cannabis Bioscience International Holdings EV-to-OCF Related Terms


Cannabis Bioscience International Holdings EV-to-OCF Historical Data

* Premium members only.

The historical data trend for Cannabis Bioscience International Holdings's EV-to-OCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cannabis Bioscience International Holdings EV-to-OCF Chart

Cannabis Bioscience International Holdings Annual Data
Trend May10 May11 May18 May19 May20 May21 May22 May23 May24 May25
EV-to-OCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -34.89 -15.07 -5.90 -13.75 -20.89

Cannabis Bioscience International Holdings Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
EV-to-OCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -24.20 -21.42 -21.38 -18.71 -18.69

CBIH vs SKYI, CBDY, NPHC: EV-to-OCF Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Bioscience International Holdings's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabis Bioscience International Holdings EV-to-OCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Bioscience International Holdings's EV-to-OCF distribution charts can be found below:

* The bar in red indicates where Cannabis Bioscience International Holdings's EV-to-OCF falls into.



Cannabis Bioscience International Holdings EV-to-OCF Calculation

Cannabis Bioscience International Holdings's EV-to-OCF for today is calculated as:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=2.731/-0.27058073113707
=-10.09

Cannabis Bioscience International Holdings's current Enterprise Value is $2.73 Mil.
Cannabis Bioscience International Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.27 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EV-to-OCF →
What does a EV-to-OCF of -10.09 mean?
Cannabis Bioscience International Holdings (CBIH) has a EV-to-OCF of -10.09 as of Sep. 20, 2026. According to the industry distribution chart, Cannabis Bioscience International Holdings ranks #181 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 18%.
Is Cannabis Bioscience International Holdings' EV-to-OCF too high?
Cannabis Bioscience International Holdings' current EV-to-OCF is -10.09. Based on the distribution chart, Cannabis Bioscience International Holdings ranks #181 out of 1007 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Cannabis Bioscience International Holdings' EV-to-OCF compare to SKYI and CBDY?
According to the Drug Manufacturers industry distribution chart, Cannabis Bioscience International Holdings ranks #181 out of 1007 companies for EV-to-OCF. This places Cannabis Bioscience International Holdings in the top 18% of its industry — outperforming the majority of peers. The industry median EV-to-OCF is 10.12. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Drug Manufacturers company?
The median EV-to-OCF among Drug Manufacturers companies is 10.12, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median EV-to-OCF is 10.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cannabis Bioscience International Holdings's current EV-to-OCF is -10.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannabis Bioscience International Holdings stock overvalued right now?
Cannabis Bioscience International Holdings (CBIH) has a current EV-to-OCF of -10.09. The current EV-to-OCF is -10.09. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Cannabis Bioscience International Holdings (CBIH), the current EV-to-OCF is -10.09 as of Sep. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cannabis Bioscience International Holdings Business Description

Address 6201 Bonhomme Road, Suite 435N, Houston, TX, USA, 77036
Cannabis Bioscience International Holdings Inc operates in three main areas. Firstly, the company engages in cannabis-related research and education under the trade name Pharmacology University. Secondly, it serves as both a Sponsor and a Contract Research Organization (CRO) in clinical trials, some of which involve cannabis and CBD products, under the trade name Alpha Research Institute. Lastly, the company plans to manufacture, market, and sell CBD products branded as "VitaCookies." The majority of the company's revenue comes from clinical trial contracts, while a smaller portion is generated from cannabis-related educational classes and seminars.